ReviewFrontiers in cell and developmental biology2025
The role of Caveolin-1 in tumor-derived extracellular vesicle biology and its implications.
Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Plasma-Derived Extracellular Vesicle-Enriched Fractions as a Potential Source of Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): A Shotgun Proteomic Exploration Analysis.Diagnostics (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor-derived extracellular vesicles (TEVs) are increasingly recognized as key mediators of intercellular communication between cancer cells and their environment, a process crucial for tumor progression. TEVs can act locally on neighboring cells or travel long distances to impact remote tissues, thereby promoting tumor growth, cell invasion, pre-metastatic niche formation, and ultimately, metastasis. Despite significant insights into the molecular mechanisms by which TEVs shape the tumor microenvironment (TME) and induce pro-metastatic effects in recipient cells, many questions remain unanswered. Recent studies suggest that caveolae, invaginations of the plasma membrane with critical roles in cellular mechanics, may play an important role in TEV-mediated metastatic trait acquisition by cancer cells. The presence of caveolin-1 (Cav1) in EVs supports its involvement in EV dynamics, including biogenesis, secretion and uptake by recipient cells. Further research into the role of Cav1 in EV-mediated cancer progression could pave the way for improved diagnostic tools and novel therapeutic strategies in cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.